<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04623658</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200355</org_study_id>
    <nct_id>NCT04623658</nct_id>
  </id_info>
  <brief_title>Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma</brief_title>
  <acronym>PROSTEO</acronym>
  <official_title>Improving Prenatal Parental Counseling in Cases of Sacrococcygeal Teratoma: a Multicenter Retrospective Study With Review of the Literature</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. However,&#xD;
      predicting factors of evolution, sequelae and relapse are still unreliable because of&#xD;
      small-cohort studies. This study aims at identifying prenatal and postnatal prognostic&#xD;
      factors of evolution of SCT during pregnancy, of postnatal relapse, and of medium and&#xD;
      long-term sequelae (urinary, digestive, esthetic, psychologic) in order to improve parental&#xD;
      counseling when the diagnosis of SCT is made during pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. Although mostly&#xD;
      benign, SCT can lead to perinatal mortality and long-term sequelae.&#xD;
&#xD;
      Three main risks occur throughout the evolution of SCT:&#xD;
&#xD;
        1. A perinatal life-threatening risk related to the importance of vascularization since SCT&#xD;
           can lead to a true arteriovenous fistula with the risk of cardiac failure&#xD;
&#xD;
        2. A risk of benign or malignant tumor recurrence&#xD;
&#xD;
        3. A risk of medium and long-term sequelae, mostly urinary and/or digestive disorders but&#xD;
           also aesthetic and psychologic.&#xD;
&#xD;
      In most cases, a prenatal diagnosis is made for which physicians are expected to give a&#xD;
      prognosis and counsel parents about medium and long-term complications. However, there is no&#xD;
      robust data to date correlating prenatal and postnatal features to prenatal and postnatal&#xD;
      evolution of the tumor. The situation is all the more delicate as the information given by&#xD;
      the physician can lead to the parent's will to terminate the pregnancy. This retrospective&#xD;
      multicentric study aims at identifying prenatal and postnatal prognostic factors of SCT&#xD;
      evolution during pregnancy, the occurrence of postnatal relapse after surgical excision, and&#xD;
      medium- and long-term sequelae. The primary goal of this study is to improve prenatal&#xD;
      parental counseling when the diagnosis of SCT is made.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 30, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of postnatal sequelae</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Presence of digestive, urinary, cosmetic or psychologic postnatal sequelae</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fetal or neonatal death</measure>
    <time_frame>Before 28 days of life</time_frame>
    <description>Intrauterine fetal death, termination of pregnancy or neonatal death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of benign or malignant recurrence</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Relapse requiring subsequent surgical procedures and/or chemotherapy</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Sacrococcygeal Teratoma</condition>
  <arm_group>
    <arm_group_label>Sacrococcygeal teratoma</arm_group_label>
    <description>Fetuses and infants diagnosed with sacrococcygeal teratoma and cared for between 2007 and 2017 in the main Parisian fetal medicine and pediatric surgery units: Necker-Enfants Malades Hospital, Antoine Béclère Hospital, Armand Trousseau Hospital, Robert Debré Hospital and Le Kremlin-Bicêtre Hospital.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Fetuses and infants diagnosed with sacrococcygeal teratoma and cared for between 2007 and&#xD;
        2017 in the main Parisian fetal medicine and pediatric surgery units: Necker-Enfants&#xD;
        Malades Hospital, Antoine Béclère Hospital, Armand Trousseau Hospital, Robert Debré&#xD;
        Hospital and Le Kremlin-Bicêtre Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fetuses and infants (&lt; 1 year) diagnosed with benign sacrococcygeal teratoma&#xD;
&#xD;
          -  Cared for between January 2007 and December 2017 in the participating centers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currarino syndrome&#xD;
&#xD;
          -  Other benign sacrococcygeal teratoma discovered after 1 year old or malignant&#xD;
             sacrococcygeal tumors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabine Sarnacki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Vinit, Resident, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Necker-Enfants Malades Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sacrococcygeal teratoma</keyword>
  <keyword>Prenatal diagnosis</keyword>
  <keyword>Prenatal counseling</keyword>
  <keyword>Prognostic factors</keyword>
  <keyword>Neonatal tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Teratoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

